Eledon Pharmaceuticals Stock Forecast - Standard Deviation

ELDN Stock  USD 4.01  0.06  1.47%   
Eledon Stock Forecast is based on your current time horizon. Although Eledon Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Eledon Pharmaceuticals' systematic risk associated with finding meaningful patterns of Eledon Pharmaceuticals fundamentals over time.
  
At this time, Eledon Pharmaceuticals' Inventory Turnover is very stable compared to the past year. As of the 25th of November 2024, Payables Turnover is likely to grow to 0.41, while Receivables Turnover is likely to drop 0.87. . As of the 25th of November 2024, Common Stock Shares Outstanding is likely to grow to about 25.9 M, though Net Loss is likely to grow to (29.5 M).
Eledon Pharmaceuticals has current Standard Deviation of 0.
Check Eledon Pharmaceuticals VolatilityBacktest Eledon PharmaceuticalsInformation Ratio  

Eledon Pharmaceuticals Trading Date Momentum

On November 25 2024 Eledon Pharmaceuticals was traded for  4.01  at the closing time. The top price for the day was 4.17  and the lowest listed price was  3.93 . There was no trading activity during the period 0.0. Lack of trading volume on November 25, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.75% .
Compare Eledon Pharmaceuticals to competition

Other Forecasting Options for Eledon Pharmaceuticals

For every potential investor in Eledon, whether a beginner or expert, Eledon Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Eledon Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Eledon. Basic forecasting techniques help filter out the noise by identifying Eledon Pharmaceuticals' price trends.

Eledon Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eledon Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Eledon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eledon Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Eledon Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Eledon Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Eledon Pharmaceuticals' current price.

Eledon Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Eledon Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eledon Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eledon Pharmaceuticals stock market strength indicators, traders can identify Eledon Pharmaceuticals entry and exit signals to maximize returns.

Eledon Pharmaceuticals Risk Indicators

The analysis of Eledon Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Eledon Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting eledon stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Eledon Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eledon Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against Eledon Stock

  0.83MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.8MTEM Molecular TemplatesPairCorr
  0.75TPST Tempest TherapeuticsPairCorr
  0.74ME 23Andme HoldingPairCorr
  0.72NKTX Nkarta IncPairCorr
The ability to find closely correlated positions to Eledon Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eledon Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eledon Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eledon Pharmaceuticals to buy it.
The correlation of Eledon Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eledon Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eledon Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eledon Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Eledon Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eledon Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eledon Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eledon Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of Eledon Pharmaceuticals to cross-verify your projections.
To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.73
Return On Assets
(0.33)
Return On Equity
(0.25)
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.